Work

Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma

Year: 2022

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-022-01235-5

Authors: Steven F. Powell, Miroslaw Mazurczak, Elie G. Dib, Jonathon S. Bleeker, Louis H. Geeraerts, Matthew Tinguely, Michele M. Lohr, Steven C. McGraw, Ashley W. Jensen, Christie A. Ellison, Lora J. Black, Susan E. Puumala, Valerie J. Reed, W. Keith Miskimins, John H. Lee, William C. Spanos

Institutions: Sanford Health, University of South Dakota, Sanford Research, Avera Health

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute of General Medical Sciences, National Institute of Dental and Craniofacial Research

Awards: Immune Dysregulation by Human Papillomavirus during Head and Neck Cancer Progression, Chemokine-mediated antigen-specific T cell responses and immunotherapies to treat head and neck cancer, G8314218910, Center for Cancer Biology

OpenAlex ID: W4220811415

FWCI: 10.36

Cites: 37

Cited by: 63

Related to: 10